News | March 10, 2023
NATCO launches additional strengths for generic version of Revlimid in USA
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
All claims against the company in the litigation have now been dismissed.
Depending on the type of cancer, it can be used as monotherapy or combination as a part of first line regimen, maintenance regimen or relapsed settings
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
The company’s Growth Portfolio delivered $6.2 billion in revenue
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Lenalidomide Capsules are indicated for the treatment of adult patients with Multiple myeloma
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Subscribe To Our Newsletter & Stay Updated
